The Medical Countermeasures against Radiation Consortium (CMCRC) is a network of national research centers working together to develop effective and comprehensive medical countermeasures applicable to all subsets of the civilian population in the event of radiological or nuclear emergencies. They utilize multidisciplinary basic and translational research to support the development of new medical products that will assess, diagnose, mitigate and/or treat the short- and long-term consequences of radiation exposure after a radiological/nuclear terrorist event or accidental exposure. This research program was originally established by NIAID in 2005 under RFA-AI-04-045 and has been reissued three more times: 2010 (RFA-AI-09-036), 2015(RFA-AI-14-055), and 2020 (RFA-AI-19-012).
Main Areas of Focus
- Produce new techniques and devices to measure radiation exposure in the human body
- Follow biomarkers of tissue damage and recovery
- Develop novel therapies to minimize tissue damage, hasten tissue recovery, restore normal physiological function, and improve survival
Radiation and Nuclear Countermeasures Program (RNCP)
Call for Pilot Project Applications
The Centers for Medical Countermeasures against Radiation Consortium (CMCRC) is now accepting applications for pilot projects. See CMCRC pilot project application instructions and forms.
Application due date: December 31, 2020
Anticipated project start date: May 1, 2021